Syringes and vials of the Pfizer-BioNTech COVID-19 vaccine are prepared to be administered to healthcare workers at a drive-up vaccination site in Reno, Nev., on Dec. 17, 2020. Patrick T. Fallon/AFP via Getty Images
New South Wales (NSW) has opened a $96 million RNA research and pilot manufacturing facility at Macquarie University, a move aimed at strengthening Australia’s ability to develop vaccines and advanced therapies locally.
The new hub will produce messenger RNA (mRNA), synthetic RNA, lipid nanoparticles, and plasmid DNA on a small scale.
We had a problem loading this article. Please enable javascript or use a different browser. If the issue persists, please visit our help center.
